Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities
Net loss	$ (2,881)	$ (27,851)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation, amortization and accretion	2,328	2,677
Impairment expense		19,453
Stock-based compensation expense	1,177	1,519
Loss from contingent consideration	128	219
Amortization of senior debt (premium) discount	145	(161)
(Gain) on sale of equipment	(42)
Inventory write-down	82	203
Other noncash adjustments	(2)	(61)
Changes in operating assets and liabilities:
Accounts receivable	(6,212)	6,525
Inventory	(2,104)	(178)
Prepaid expenses and other current assets	(1,801)	279
Accounts payable and other	3,587	(9,888)
Accrued liabilities	(3,481)	3,326
Other operating assets and liabilities, net	(72)	147
Net cash used in operating activities	(9,148)	(3,791)
Investing Activities
Contingent consideration payment		(50)
Other investing activities	42	(36)
Net cash provided by (used in) investing activities	42	(86)
Financing Activities
Proceeds from issuance of stock	10,416	307
Payment of stock issuance costs	(793)	(21)
Payment made to fixed payment arrangement	(301)	(2,305)
Proceeds from short-term line of credit	34,791	42,212
Payments made on short-term line of credit	(30,517)	(45,626)
Payments made to borrowings	(26)	(25)
Other financing activities	(13)	(6)
Net cash provided by (used in) financing activities	13,557	(5,464)
Net change in cash, cash equivalents, and restricted cash	4,451	(9,341)
Cash, cash equivalents and restricted cash at beginning of period	19,360	49,901
Cash, cash equivalents and restricted cash at end of period	23,811	40,560
Supplemental cash flow data
Cash paid for interest	565	1,688
Non-cash investing and financing activities:
Warrants issued	3,023
Other noncash investing and financing activities	$ 146	16
Fixed payment arrangements included in accrued liabilities		$ 525